Nutritional prevention of urological tumours - Abstract

Through the last decade considerations on the role of vitamins and antioxidants in the primary prevention of genitourinary tumors have changed dramatically.

In spite of all efforts, the efficacy of a specific compound has not been proven so far. In consequence, recommendations to use vitamins or other supplements for the primary prevention of urological tumors should be avoided. However, there is some evidence that moderate food consumption, reduction of dairy products and an Asian or Mediterranean diet may not only prevent prostate cancer (PCA) but also harbour additional beneficial effects on general health. Although quantification of these findings may be difficult, it becomes evident that these measures will have additional synergistic effects on cardiovascular diseases. Considering the large number of PCA patients dying not cancer-related but from concomitant diseases, primary prevention in particular of PCA should always also consider the general health of the target population. More recent studies suggest a potential effect of nutritional compounds on biochemical tumour recurrence in PCA patients after definite therapy. These observations may serve as a starting point for validation within controlled clinical trials.

Written by:
Schmitz-Dräger BJ, Sahin S, Lümmen G, Bismarck E, Fischer C.   Are you the author?
Urologie24, Schön Klinik Nürnberg Fürth, Fürth; Urologische Abteilung, St. Josef-Hospital, Troisdorf; Urologische Klinik, Klinikum Hohe Warte, Bayreuth.

Reference: Aktuelle Urol. 2014 Jul;45(4):281-5.
doi: 10.1055/s-0034-1383645


PubMed Abstract
PMID: 25166608

Article in German.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe